Medical Imaging of Electroporation

  • Eisuke Ueshima
  • Govindarajan Srimathveeravalli
  • Stephen B Solomon
Living reference work entry
First Online:
Received:
Accepted:

Abstract

Irreversible electroporation (IRE) is emerging as an important option for the minimally invasive focal ablation of tumors in the liver, pancreas, prostate, and kidney. Imaging plays a crucial role in selection of appropriate pulse parameters, electrode placement, monitoring of pulse delivery, and evaluating outcomes of IRE. The ability to clearly distinguish between regions of reversible and irreversible electroporation is crucial for the effective treatment of tumors. As electroporation itself cannot be directly visualized in patients, the imaging of tissue changes that arise following electroporation such as changes in perfusion, vascular permeability, diffusion, and functional or metabolic state of tissue is used to monitor IRE in patients. Several imaging techniques, such as computed tomography (CT), ultrasound (US), magnetic resonance imaging (MRI), and positron emission tomography (PET) are now used for guiding and assessing IRE in vivo. In this chapter, typical imaging features that manifest following IRE are discussed and the physiologic effects that underlie these features as seen with different imaging techniques in malignant and normal tissue in the liver, prostate, and other major organs are described.

Keywords

Irreversible Electroporation (IRE) Computed Tomography (CT) Magnetic Resonance Imaging (MRI) Ultrasound (US) Positron Emission Tomography (PET) 
This is a preview of subscription content, log in to check access.

References

  1. Akinwande O, Ahmad SS, Van Meter T, Schulz B, Martin RC (2015) CT findings of patients treated with irreversible electroporation for locally advanced pancreatic cancer. J Oncol 2015:680319. doi:10.1155/2015/680319CrossRefGoogle Scholar
  2. Appelbaum L, Ben-David E, Faroja M, Nissenbaum Y, Sosna J, Goldberg SN (2014) Irreversible electroporation ablation: creation of large-volume ablation zones in in vivo porcine liver with four-electrode arrays. Radiology 270(2):416–424. doi:10.1148/radiol.13130349CrossRefGoogle Scholar
  3. Au JT, Kingham TP, Jun K, Haddad D, Gholami S, Mojica K, Monette S, Ezell P, Fong Y (2013) Irreversible electroporation ablation of the liver can be detected with ultrasound B-mode and elastography. Surgery 153(6):787–793. doi:10.1016/j.surg.2012.11.022CrossRefGoogle Scholar
  4. Barabasch A, Distelmaier M, Heil P, Krämer NA, Kuhl CK, Bruners P (2017) Magnetic resonance imaging findings after percutaneous irreversible electroporation of liver metastases: a systematic longitudinal study. Investig Radiol 52(1):23–29CrossRefGoogle Scholar
  5. Chung DJ, Sung K, Osuagwu FC, Wu HH, Lassman C, Lu DS (2016) Contrast enhancement patterns after irreversible electroporation: experimental study of CT perfusion correlated to histopathology in normal porcine liver. J Vasc Interv Radiol 27(1):104–111. doi:10.1016/j.jvir.2015.09.005CrossRefGoogle Scholar
  6. Ellis TL, Garcia PA, Rossmeisl JH Jr, Henao-Guerrero N, Robertson J, Davalos RV (2011) Nonthermal irreversible electroporation for intracranial surgical applications Laboratory investigation. J Neurosurg 114(3):681–688. doi:10.3171/2010.5.JNS091448CrossRefGoogle Scholar
  7. Granata V, Fusco R, Catalano O, Piccirillo M, De Bellis M, Izzo F, Petrillo A (2015) Percutaneous ablation therapy of hepatocellular carcinoma with irreversible electroporation: MRI findings. AJR Am J Roentgenol 204(5):1000–1007. doi:10.2214/AJR.14.12509CrossRefGoogle Scholar
  8. Guo Y, Zhang Y, Klein R, Nijm GM, Sahakian AV, Omary RA, Yang GY, Larson AC (2010) Irreversible electroporation therapy in the liver: longitudinal efficacy studies in a rat model of hepatocellular carcinoma. Cancer Res 70(4):1555–1563. doi:10.1158/0008-5472.CAN-09-3067CrossRefGoogle Scholar
  9. Guo Y, Zhang Y, Nijm GM, Sahakian AV, Yang GY, Omary RA, Larson AC (2011) Irreversible electroporation in the liver: contrast-enhanced inversion-recovery MR imaging approaches to differentiate reversibly electroporated penumbra from irreversibly electroporated ablation zones. Radiology 258(2):461–468. doi:10.1148/radiol.10100645CrossRefGoogle Scholar
  10. Hjouj M, Rubinsky B (2010) Magnetic resonance imaging characteristics of nonthermal irreversible electroporation in vegetable tissue. J Membr Biol 236(1):137–146. doi:10.1007/s00232-010-9281-2CrossRefGoogle Scholar
  11. Hjouj M, Last D, Guez D, Daniels D, Sharabi S, Lavee J, Rubinsky B, Mardor Y (2012) MRI study on reversible and irreversible electroporation induced blood brain barrier disruption. PLoS One 7(8):e42817. doi:10.1371/journal.pone.0042817CrossRefGoogle Scholar
  12. Kranjc M, Markelc B, Bajd F, Čemažar M, Serša I, Blagus T, Miklavčič D (2015) In situ monitoring of electric field distribution in mouse tumor during electroporation. Radiology 274(1):115–123. doi:10.1148/radiol.14140311CrossRefGoogle Scholar
  13. Lee EW, Loh CT, Kee ST (2007) Imaging guided percutaneous irreversible electroporation: ultrasound and immunohistological correlation. Technol Cancer Res Treat 6(4):287–294CrossRefGoogle Scholar
  14. Lee EW, Chen C, Prieto VE, Dry SM, Loh CT, Kee ST (2010) Advanced hepatic ablation technique for creating complete cell death: irreversible electroporation. Radiology 255(2):426–433. doi:10.1148/radiol.10090337CrossRefGoogle Scholar
  15. Lee YJ, Lu DS, Osuagwu F, Lassman C (2012) Irreversible electroporation in porcine liver: short- and long-term effect on the hepatic veins and adjacent tissue by CT with pathological correlation. Investig Radiol 47(11):671–675. doi:10.1097/RLI.0b013e318274b0dfCrossRefGoogle Scholar
  16. Lee YJ, Lu DS, Osuagwu F, Lassman C (2013) Irreversible electroporation in porcine liver: acute computed tomography appearance of ablation zone with histopathologic correlation. J Comput Assist Tomogr 37(2):154–158. doi:10.1097/RCT.0b013e31827dbf9bCrossRefGoogle Scholar
  17. Mahmood F, Hansen RH, Agerholm-Larsen B, Gissel H, Ibsen P, Gehl J (2015) Detection of electroporation-induced membrane permeabilization states in the brain using diffusion-weighted MRI. Acta Oncol 54(3):289–297. doi:10.3109/0284186X.2014.991045CrossRefGoogle Scholar
  18. Neal RE II, Cheung W, Kavnoudias H, Thomson KR (2012) Spectrum of imaging and characteristics for liver tumors treated with irreversible electroporation. Biomed Sci Eng 5:813–818. doi:10.4236/jbise.2012.512A102CrossRefGoogle Scholar
  19. Ryan ER, Sofocleous CT, Schöder H, Carrasquillo JA, Nehmeh S, Larson SM, Thornton R, Siegelbaum RH, Erinjeri JP, Solomon SB (2013) Split-dose technique for FDG PET/CT-guided percutaneous ablation: a method to facilitate lesion targeting and to provide immediate assessment of treatment effectiveness. Radiology 268(1):288–295. doi:10.1148/radiol.13121462CrossRefGoogle Scholar
  20. Srimathveeravalli G, Cornelis F, Mashni J, Takaki H, Durack JC, Solomon SB, Coleman JA (2016) Comparison of ablation defect on MR imaging with computer simulation estimated treatment zone following irreversible electroporation of patient prostate. Springerplus 5:219. doi:10.1186/s40064-016-1879-0CrossRefGoogle Scholar
  21. Sugimoto K, Moriyasu F, Kobayashi Y, Kasuya K, Nagakawa Y, Tsuchida A, Hara T, Iobe H, Oshiro H (2015 Feb) Assessment of various types of US findings after irreversible electroporation in porcine liver: comparison with radiofrequency ablation. J Vasc Interv Radiol 26(2):279.e3–287.e3. doi:10.1016/j.jvir.2014.11.007CrossRefGoogle Scholar
  22. van den Bos W, de Bruin DM, van Randen A, Engelbrecht MR, Postema AW, Muller BG, Varkarakis IM, Skolarikos A, Savci-Heijink CD, Jurhill RR, Zondervan PJ, Laguna Pes MP, Wijkstra H, de Reijke TM, de la Rosette JJ (2016 Jul) MRI and contrast-enhanced ultrasound imaging for evaluation of focal irreversible electroporation treatment: results from a phase I-II study in patients undergoing IRE followed by radical prostatectomy. Eur Radiol 26(7):2252–2260. doi:10.1007/s00330-015-4042-3CrossRefGoogle Scholar
  23. Vroomen LG, Scheffer HJ, Melenhorst MC, de Jong MC, van den Bergh JE, van Kuijk C, van Delft F, Kazemier G, Meijerink MR (2016) MR and CT imaging characteristics and ablation zone volumetry of locally advanced pancreatic cancer treated with irreversible electroporation. Eur Radiol. Epub ahead of print. PMID:27659702. DOI:10.1007/s00330-016-4581-2Google Scholar
  24. Wendler JJ, Porsch M, Hühne S, Baumunk D, Buhtz P, Fischbach F, Pech M, Mahnkopf D, Kropf S, Roessner A, Ricke J, Schostak M, Liehr UB (2013) Short- and mid-term effects of irreversible electroporation on normal renal tissue: an animal model. Cardiovasc Intervent Radiol 36(2):512–520. doi:10.1007/s00270-012-0452-7CrossRefGoogle Scholar
  25. Zhang Y, Guo Y, Ragin AB, Lewandowski RJ, Yang GY, Nijm GM, Sahakian AV, Omary RA, Larson AC (2010) MR imaging to assess immediate response to irreversible electroporation for targeted ablation of liver tissues: preclinical feasibility studies in a rodent model. Radiology 256(2):424–432. doi:10.1148/radiol.10091955CrossRefGoogle Scholar

Copyright information

© Springer International Publishing AG 2016

Authors and Affiliations

  • Eisuke Ueshima
    • 1
  • Govindarajan Srimathveeravalli
    • 1
  • Stephen B Solomon
    • 1
  1. 1.Interventional Radiology Service, Department of RadiologyMemorial Sloan Kettering Cancer CenterNew YorkUSA

Personalised recommendations